1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. SEQUENT SCIENTIFIC LTD.
Sequent Scientific Ltd. NSE: SEQUENT | BSE: 512529
200.64 2.05 (1.03%)
1.8M
NSE+BSE Volume
High volume today

NSE 19 Sep, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert



Board Meetings - Sequent Scientific Ltd.

The latest board meeting for Sequent Scientific Ltd. took place on 08 Aug 2025, for the purpose of Quarterly Results

Ex-date Purpose Notes
08 Aug 2025 Quarterly Results -
20 May 2025 Audited Results & Final Dividend -
11 Feb 2025 Quarterly Results -
13 Nov 2024 Quarterly Results -
14 Aug 2024 Quarterly Results -
15 May 2024 Audited Results & Final Dividend -
13 Feb 2024 Quarterly Results -
06 Nov 2023 Quarterly Results -
10 Aug 2023 Quarterly Results -
23 May 2023 Audited Results & Dividend -
14 Feb 2023 Quarterly Results -
07 Nov 2022 Quarterly Results & Preferential issue -
08 Aug 2022 Quarterly Results -
25 May 2022 Audited Results -
11 Feb 2022 Quarterly Results -
01 Nov 2021 Quarterly Results -
10 Aug 2021 Quarterly Results -
30 Jun 2021 Audited Results & Final Dividend -
03 Feb 2021 Quarterly Results -
06 Nov 2020 Quarterly Results -
30 Jul 2020 Quarterly Results -
12 May 2020 Audited Results -
28 Jan 2020 Quarterly Results -
13 Nov 2019 Quarterly Results -
31 Jul 2019 Quarterly Results -
14 May 2019 Audited Results & Dividend -
01 Feb 2019 Quarterly Results -
02 Nov 2018 Quarterly Results -
09 Aug 2018 Quarterly Results -
24 May 2018 Audited Results & Dividend -
09 Feb 2018 Quarterly Results -
09 Nov 2017 Quarterly Results & Interim Dividend -
03 Aug 2017 Quarterly Results -
23 May 2017 Audited Results & Dividend -
10 Feb 2017 Quarterly Results -
10 Nov 2016 Quarterly Results -
12 Aug 2016 Quarterly Results -
14 May 2016 Audited Results & Dividend -
11 Feb 2016 Quarterly Results Inducted Mr. K E C Raja Kumar as an Additional Director (Non-Executive) on the Board of the Company.
29 Oct 2015 Quarterly Results Approved the sub-division (stock split) of one equity share of the Company having a face value of Rs. 10/- each into five equity shares of face value of Rs. 2/- each.
30 Jul 2015 Quarterly Results -
10 Jun 2015 Others Allotted 800,000 equity shares at Rs. 222.15 per share and 200,000 equity shares at Rs. 236 per share to M/s. Chayadeep Ventures LLP.
22 May 2015 Others Approved the issue price of Rs. 535/- per Equity Share to be allotted to qualified institutional buyers through the QIP.
24 Apr 2015 Audited Results & Dividend -
12 Nov 2014 Quarterly Results -
13 Aug 2014 Quarterly Results -
28 May 2014 Audited Results & Dividend -
12 Feb 2014 Quarterly Results -
13 Nov 2013 Quarterly Results -
14 Aug 2013 Quarterly Results -
30 May 2013 Audited Results & Dividend -
14 Feb 2013 Quarterly Results -
07 Nov 2012 Quarterly Results To change the registerd office.
14 Aug 2012 Quarterly Results -
24 May 2012 Audited Results & Dividend -
09 Feb 2012 Quarterly Results -
21 Oct 2011 Quarterly Results -
12 Aug 2011 Quarterly Results -
27 May 2011 Audited Results & Dividend (Revised)
10 Feb 2011 Quarterly Results -
29 Oct 2010 Quarterly Results -
13 Aug 2010 Quarterly Results -
28 May 2010 Audited Results & Dividend -
29 Mar 2010 Employees Stock Option Plan & Others To allot 700000 Equity Shares of Rs. 10/- each to M/s. SEQUENT SCIENTIFIC EMPLOYEE STOCK OPTION PLAN TRUST as created to implement the ESOP & to differ the decision on amalgamation of SRL with Co.
27 Jan 2010 Quarterly Results -
29 Oct 2009 Quarterly Results (Revised)
22 Sep 2009 Scheme of Amalgamation The Board considered pursuant to the SoA of M/s. Sequent Scientific Ltd. with the Company 10,150,000 equity shares of Rs. 10/- each were allotted to the Shareholders of M/s. Sequent Scientific Ltd.
16 Sep 2009 Issue & Allotment of Securities -
31 Jul 2009 Quarterly Results -
22 Jun 2009 Audited Results & Dividend -
30 Jan 2009 Quarterly Results -
22 Oct 2008 Quarterly Results -
29 Jul 2008 Quarterly Results & Amalgamation To acquire Sequent Scientific Ltd by way of an amalgamation of Sequent into itself & to recommend a merger ratio to the Board to enable it to present the same to stock exchange. (Revised)
27 Jun 2008 Audited Results & Dividend -
29 Jan 2008 Quarterly Results -
25 Oct 2007 Quarterly Results -
23 Jul 2007 Quarterly Results -
20 Jun 2007 Audited Results & Dividend -
31 Jan 2007 Quarterly Results -
30 Oct 2006 Quarterly Results -
07 Sep 2006 Accounts -
31 Jul 2006 Quarterly Results -
30 Apr 2006 Quarterly Results -
20 Apr 2006 Issue of warrants on preferential basis Acquisition of another unlisted Company engaged in similar line of pharma business & Reclassification of authorised capital of the Company
30 Jan 2006 Quarterly Results -
29 Oct 2005 Quarterly Results -
30 Jul 2005 Quarterly Results -
30 Apr 2005 Quarterly Results & Others To consider to redeem Cumulative Optional Convertible Preference Shares alloted pursuant to the Scheme of Amalgamation.
31 Jan 2005 Quarterly Results -
18 Aug 2004 Dividend & Accounts -
29 Apr 2004 Quarterly Results -
30 Jan 2004 Quarterly Results -
20 Nov 2003 Others To give effect to the various clauses of the Scheme of Amalgamation of M/s P.I.Drugs & Pharmaceuticals Ltd with the company as sanctioned by the High Court.
31 Oct 2003 Quarterly Results -
31 Jul 2003 Quarterly Results -
31 Jan 2003 Quarterly Results -
03 Jan 2003 Others To consider the report of the commitee of Directors in respect of acquisition of business of P.I. Drugs & Pharmaceuticals Ltd.
09 Dec 2002 Others Feasibility of acquisition of P.I.Drugs & Pharmaceuticals Ltd. and manner of such acquisition & resolved on the steps to be taken.
14 Oct 2002 Quarterly Results -
28 Jun 2002 Accounts & Dividend -